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3181 SW Sam Jackson Park Road, Portland, OR 97239, USAReceived 19 May 2009; received in revised form 21 September 2009; accepted 21 September 2009Abstract Asymmetric stem cell division has emerged as a major regulatory mechanism for
physiologic control of stem cell numbers. Reinvigoration of the cancer stem cell theory suggests that tumorigenesis may be
regulated by maintaining the balance between asymmetric and symmetric cell division. Therefore, mutations affecting this
balance could result in aberrant expansion of stem cells. Although a number of molecules have been implicated in regulation of
asymmetric stem cell division, here, we highlight known tumor suppressors with established roles in this process. While a subset
of these tumor suppressors were originally defined in developmental contexts, recent investigations reveal they are also lost or
mutated in human cancers. Mutations in tumor suppressors involved in asymmetric stem cell division provide mechanisms by
which cancer stem cells can hyperproliferate and offer an intriguing new focus for understanding cancer biology. Our discussion
of this emerging research area derives insight from a frontier area of basic science and links these discoveries to human
tumorigenesis. This highlights an important new focus for understanding the mechanism underlying expansion of cancer stem
cells in driving tumorigenesis.
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The ability of stem cells to undergo asymmetric cell division
as a way to self-renew is a tightly regulated process that
occurs during development, tissue maintenance, and re-
generation, and may be disrupted in hyperproliferative
disease states such as cancer. Asymmetric cell division is
typically restricted to stem cell populations where a need
exists to preserve both a progenitor and a simultaneously
generated differentiated progeny. This process is nicely
exemplified in self-renewing tissues such as the epithelial
layer of the human skin and intestine. Both organs possess
stem cell pools that derive differentiated epithelia needed
to maintain the function of the organ. The stem cell employs
asymmetric division to maintain an appropriate census of
daughter cells (or transient amplifying cells) and terminally
differentiated cells. In the intestine, transient amplifying
cells are characterized by their ability to amplify the
epithelial population and likely undergo symmetric cell
division to generate terminally differentiated cell popula-
tions. In these self-renewing tissues, a critical balance
between asymmetric and symmetric cell division is required
to maintain tissue homeostasis. Asymmetric stem cell
division is vital for this maintenance; thus, it is likely that
tumors will develop if it is not properly regulated (Fig. 1a)
(Morrison and Kimble, 2006). This dysregulation is consistent
with the notion that expansion of a subpopulation of cancer
cells harboring stem cell-like properties (cancer stem cells)
may be the basis for propagating tumorigenesis. Though still
controversial, there is growing acceptance that tumors may
be dictated by this stem cell hierarchy; knowledge of how
mutations in molecules that influence asymmetric stem cell
division will provide insight into tumorigenesis. Mechanisms
of asymmetric stem cell division have primarily been
elucidated in invertebrate systems and encompass a number
of molecules highly conserved in vertebrates (Morrison and
Kimble, 2006; Knoblich, 2008; Doe, 2008; Yu et al., 2006).
A subset of proteins important for regulating asymmet-
ric stem cell division are known tumor suppressors
expressed in both invertebrate and vertebrate systems.
Many of these tumor suppressors in Drosophila melanoga-
ster have a role in tumor formation, and many of these
genes have human homologues. Whether the function of
these tumor suppressors in asymmetric stem cell division
significantly contributes to cancer progression in verte-
brate systems is not yet fully established; however, based
on evolutionary conservation, it is intriguing to speculate
that they may play an important role in human cancers.
Our intention is to review the role of four specific tumor
suppressors involved in asymmetric stem cell division and
discuss potential roles for their function in human cancer.
Importantly, the lessons learned from the consequences of
misregulating asymmetric stem cell division in developmen-
tal systems can inform the emerging research focus on the
mechanism underlying cancer stem cell expansion as it
relates to tumor progression.Much of what is known about the molecular mechanism
underlying asymmetric cell division is based on examination
of developmental systems in Drosophila. Through elegant
studies of the Drosophila neuroblast and germline cells, we
know that the polarity and spindle orientation of the stem
cell—the major determinants of asymmetric stem cell
division—are governed by factors that are both intrinsic
and extrinsic (Knoblich, 2008; Doe, 2008; Yu et al., 2006;
Bilder, 2004). For example, in the fly neural stem cells or
“neuroblasts,” segregation of intracellular proteins to the
apical or basolateral region of the cell determines whether a
stem cell asymmetrically divides, giving rise to both a stem
cell and a differentiated daughter cell, or if it symmetrically
divides to produce two stem cells (Lee et al., 2006; Bowman
et al., 2006). In contrast, Drosophila germline cells rely on
extrinsic factors within the stem cell niche to define the
orientation of the mitotic spindle, which is critical for proper
cell division (Yamashita et al., 2003, 2007). In addition,
proper cell division of the self-renewing, polarized mouse
intestinal epithelium is regulated by the positioning of the
mitotic spindle (Fleming et al., 2007). From these two model
systems, it is clear that both the orientation of the spindle
and segregation of polarity components ultimately deter-
mine whether a stem cell will asymmetrically or symmetri-
cally divide.
While it is yet unclear if these two well-defined examples
of asymmetric stem cell division directly apply to division of
human stem cells or to a putative cancer stem cell
population, they offer a testable model to shape our
investigation of the link between mammalian cancer and
stem cell biology. Moreover, emerging evidence from the fly
and mouse suggests that mutations in particular tumor
suppressors that govern asymmetric stem cell division
disrupt the normal ratio of stem cells to differentiated
cells and contribute to unregulated proliferation of tumors.
The following tumor suppressors—Adenomatous polyposis
coli (Apc), Lethal giant larvae (Lgl), Brain tumor (Brat) and
p63—display a novel and intriguing link between inverte-
brates and vertebrates and the regulation of asymmetric
stem cell division in both tissue stem cells and tumorigenesis.Adenomatous polyposis coli: A novel role in
stem cell mitotic spindle orientation
APC is a human tumor suppressor with a well-documented
role in the Wnt signaling pathway, primarily governing
proliferative division of stem cells (Morin et al., 1996;
Rubinfeld et al., 1997). In this capacity mutations in APC
result in upregulated cellular proliferation and tumor
formation. Not surprisingly, this gene is mutated or sup-
pressed in a number of cancers, including hepatoblastoma
(Oda et al., 1996), medulloblastoma (Huang et al., 2000),
adult T-cell leukemia (Yang et al., 2005), and most notably in
colorectal cancer where nearly all forms harbor mutations in
APC (Su et al., 2000). The dominant association between the
Figure 1 Model illustrating howmutations in factors regulating asymmetric stem cell division in Drosophila neuroblast and germline
cells result in uncontrolled expansion of stem cells. (a) Stem cells can undergo asymmetric division giving rise to both a stem cell (white)
and a differentiated cell (gray), or symmetric division that produces two stem cells. (b) In the Drosophila germline stem cells (GSC)
asymmetric cell division requires Adenomatous polyposis coli-2 (Apc2; green oval) and its partners DE-cadherin and Armadillo (Arm)/β-
catenin (purple) at the HUB cell interface to support proper mitotic spindle orientation, as well as additional microenvironmental
extrinsic cues (yellow arrows). This yields one GSC and one Gonialblast. However, mutations in tumor suppressors result in symmetric
cell division that yields two GSCs and consequent hyperproliferation of the stem cell pool. (c) Asymmetric division of the Drosophila
neuroblast requires correct localization of the apical complex (red crescent), atypical Protein Kinase C-Bazooka-Par6, Inscuteable,
Partner of Inscuteable, and Gαi (aPKC-Baz-Par6, Ins, Pins, and Gαi), and basal restriction of Lethal giant larvae-Discs large-Scribble,
Brain tumor, Miranda, Prospero, Numb (Lgl-Dlg-Scrib, Brat, Mira, Pros, Numb; blue crescent). Normal asymmetric neuroblast division
results in self-renewal of the stem cell and production of a differentiated ganglion mother cell (GMC). Mutations in tumor suppressors
cause mislocalization of the basal proteins and thus generate two neuroblasts resulting in uncontrolled stem cell proliferation.
5Asymmetric stem cell division in cancerAPC and theWnt signaling pathway overshadows the multiple
functions of the APC protein (reviewed in Hanson and Miller,
2005). The human APC gene encodes a large multidomain
protein that can interact with a number of partner proteins
(Hanson and Miller, 2005). As such, APC has been demon-
strated to interact withmicrotubules, suggesting a role in cell
migration (Hanson and Miller, 2005; Dikovskaya et al., 2007;
Kroboth et al., 2007). Additionally, it has been shown to be
involved in regulating mitotic spindle assembly and chromo-
some segregation (Kaplan et al., 2001). Further, APC has also
been described to participate in regulation of cell cycle
progression and apoptosis (Dikovskaya et al., 2007; Baeg
et al., 1995). Although each of these roles attributed to APC
has potential importance in tumor progression, its role in
asymmetric stem cell division most intriguingly suggests an
important function in modulating expansion of cancer stem
cells. Recently, Apc was discovered to be a component of the
centrosome complex of Drosophila germline cells. Here it
functions in establishing asymmetric stem cell division,distinct from its role in Wnt signaling. In this capacity, muta-
tions in APC could effectively expand early cancer cells or a
putative cancer stem cell pool.
In the male Drosophila germline, Apc2 anchors the mother
centrosome of the germline stem cell so that it is adjacent to
the hub cell. The hub cell provides extrinsic, supportive cues
to the stem cell that orient the mitotic spindle. The contact
surface between the hub cell and the germline stem cell is
also marked by concentrated levels of proteins known to
interact with Apc2 (Fig. 1b). This interaction localizes Apc2
to the interface between the hub germline stem cell, fixing
the mother centrosome at one pole of the stem cell and
allowing the daughter centrosome to migrate to the opposite
side of the germline stem cell (Fig. 1b). This movement
allows the correct orientation of the mitotic spindle
(Yamashita et al., 2007; Penman et al., 2005). In Droso-
phila, deletion of both Apc genes results in misorientation of
centrosomes and the mitotic spindle, and consequently
disrupts asymmetric stem cell division. At the tissue level,
6 A.E. Powell et al.the phenotypic consequence is hyperproliferation of germ-
line stem cells at the expense of differentiated cells
(Yamashita et al., 2003).
To date, the most well investigated role of APC has been
its function as a tumor suppressor. However, these new
findings in Drosophila reveal a novel role for Apc in asym-
metric stem cell division, which may intensify its role in
tumor progression. It is easy to speculate that APC in humans
may also be essential for spindle orientation and proper
asymmetric division of tissue stem cells. In this scenario,
mutations in APC would also lead to increased numbers of
cancer stem cells. Investigation of APC's role in the regu-
lation of asymmetric stem cell division represents an
important future focus of human cancer biology.
Lethal giant larvae: Regulating stem cell
polarity and differentiation
Normal asymmetric neuroblast division results in self-
renewal of the stem cell and production of a differentiated
ganglion mother cell (GMC; Fig. 1c). The correct positioning
of both apical and basal protein complexes is critical for
proper asymmetric cell division. Mutations in tumor
suppressors cause mislocalization of these basal proteins,
generating two neuroblasts that result in uncontrolled stem
cell proliferation (Fig. 1c). Three Drosophila tumor sup-
pressor genes, lethal giant larvae (lgl), discs-large (dlg),
and scribble (scrib), act in a common pathway in the
mitotic neuroblast to establish the asymmetrically localized
cortical basal complex and ultimately influence asymmetric
stem cell division. Specifically, Lgl interacts with the apical
complex shown in Fig. 1c—atypical protein kinase C-
Bazooka-Par6, Inscuteable, Partner of Inscuteable, and
Gαi (aPKC, Ins, Pins, and Gαi). In addition, it restricts the
localization of active basal complex molecules (Wirtz-Peitz
et al., 2008; Betschinger et al., 2003) and this is illustrated
in mutants for Lgl that possess abnormal targeting of the
basal complex proteins Miranda, Prospero, and Numb (Mira,
Pros, Numb) (Fig. 1c; Lee et al., 2006; Betschinger et al.,
2003).
Proper location and function of Lgl is critical to the
prevention of tumor formation. Lgl mutants do not asym-
metrically divide but instead produce two stem cells at the
expense of neuronal populations. This ultimately leads to
expansion of the stem cell population and subsequent
formation of brain tumors (Lee et al., 2006). Supporting
this role in tumor suppression and the regulation of proper
asymmetric cell division, loss of mouse Lgl1 results in
disrupted asymmetric cell division and a brain tumor
phenotype (Klezovitch et al., 2004). Tumor initiation and
cancer progression in humans may, in part, be driven by
misregulation of Lgl homologues. Strikingly, a human
homologue of lgl, HUGL-1, is lost in many solid tumors and
is strongly correlated with advanced stages of malignant
melanoma, colorectal cancer, and endometrial cancer
(Kuphal et al., 2006; Schimanski et al., 2005; Tsuruga
et al., 2007). In addition, recent work examining HUGL-1 in
human hepatocellular carcinoma reveals that the mRNA is
frequently mutated by aberrant splicing. This renders the
protein inactive and functions as an important mediator of
hepatocellular carcinoma progression (Lu et al., 2009).HUGL-1 is highly structurally and functionally conserved,
as observed by the ability of HUGL-1 to rescue Drosophila lgl
mutants (Grifoni et al., 2004). Both HUGL-1 and another Lgl
human homologue, HUGL-2, directly interact with the human
aPKC-Par6 protein complex (Yasumi et al., 2005) (Fig. 1c),
behaving just as Lgl does in Drosophila. Further, inhibition of
this binding induces disorganization of the mitotic spindle
during normal mitosis and results in aberrant cell division
(Yasumi et al., 2005). Even further evidence from the
examination of the behavior of Drosophila polarity proteins
in human ovarian cancer epithelium reveals that Lgl function
is conserved (Grifoni et al., 2007) between flies and humans.
This suggests that both HUGL-1 and HUGL-2 play active roles
in establishing polarity and spindle orientation for asymmet-
ric cell division of human epithelial stem cells and, when
mutated, may result in tumor initiation and/or expansion of
cancer stem cells. This intriguing possibility has yet to be
directly investigated.
Brat: A critical protein for balancing stem cell
self-renewal and proliferation
The Drosophila larval neuroblast tumor suppressor with
emerging relevance to human cancer is the newest member
of the basal complex, “Brain tumor” (brat, Fig. 1c). Brat, like
Prospero, Miranda, and Numb, is asymmetrically localized
during neuroblast cell division to the basal cortex (Fig. 1c).
Brat removal results in extensive proliferation of larval
neuroblasts at the expense of differentiated neurons and
generates tumors (Lee et al., 2006; Betschinger et al., 2006).
Further investigation revealed that Brat mutants exhibit and
uncontrolled expansion of transient amplifying cells, result-
ing from a failure to progress through the cell cycle (Bowman
et al., 2008).
The structure of Brat contains clues about its role in
asymmetric stem cell division and control of tissue prolifer-
ation. Brat contains an NHL domain, an evolutionarily
conserved motif found in proteins that posttranscriptionally
regulate gene expression via mRNA binding and inhibition of
translation. Indeed, in Drosophila, Brat is thought to be a
posttranscriptional inhibitor of Myc (Sonoda and Wharton,
2001). Myc transcriptionally regulates a variety of cell cycle
and cell growth genes to support proliferation as opposed to
differentiation. Interestingly, dMyc translation is de-re-
pressed in cells without Brat. Studies in the mouse neocortex
support this finding where TRIM32, a Brat homologue, is
asymmetrically localized in one of the two daughter cells and
becomes upregulated during neuronal differentiation
(Schwamborn et al., 2009). TRIM32 has dual roles both as a
tumor suppressor functioning to degrade cMyc and in
asymmetric cell division where it is asymmetrically located
and activates certain microRNAs important for stem cell self-
renewal (Schwamborn et al., 2009). Although a role for
TRIM32 in asymmetric stem cell division in human cancers
has not been described, its overexpression in human head
and neck squamous cell carcinoma samples highlights its
activity as an E3 ubiquitin ligase (Horn et al., 2004; Locke et
al., 2009; Albor and Kulesz-Martin, 2007; Boulay et al.,
2009), and it has been suggested to potentially be a cause of
cancer. This analysis is complicated by functional redundan-
cy in the mouse and human systems, as both species also
7Asymmetric stem cell division in cancerexpress TRIM2 and TRIM3, which are also human Brat
homologues. To this end, loss of heterozygosity of the
tumor suppressor TRIM3 has recently been implicated in
human malignant gliomas (Boulay et al., 2009), where it is
intriguing to speculate that it may have a role in asymmetric
cell division and formation of a potential cancer stem cell
population. Clearly, additional studies are required to
establish a role for the Brat family homologues in asymmetric
stem cell division in humans. However, the intriguing
evidence from mouse and fly suggests that Brat is certainly
multifunctional. Importantly, like the APC tumor suppressor,
Brat is most well-known for an early described function in
tumorigenesis that overshadows a potentially important role
in asymmetric stem cell division specifically contributing to
cancer stem cell expansion.
p63: A novel role in stem cell spindle
orientation and proliferation
While numerous studies have examined asymmetric cell
division in invertebrates, recent reports have uncovered a
role for this process in mammalian systems. For example,
p63, a closely related member of the p53 tumor suppressor
family, is highly expressed in asymmetrically dividing
stratified epithelial cells that are susceptible to cancer
(Yang et al., 1999). p63 has been implicated and is now
classically described as a master switch regulator of epithe-
lial stem cell commitment, maintenance, and differentiation
(Koster et al., 2004).
In both mouse and human, full-length p63 is spliced into
multiple isoforms and all of the resulting protein products
have distinct, complex roles described in both oncogenesis
and tumor suppression, depending on the tissue- and/or
tumor-specific context for which they are examined
(Westfall, 2004; Deyoung, 2007). For example, ΔNp63α is
upregulated in breast, gastric, cholangiocarcinoma, and
chronic myeloid leukemia, but not in leukemia, where the
TAp63 isoform is overexpressed. In addition, molecular
interactions between the isoforms, which limit the activity
of one another, have also been described, further compli-
cating analyses of these proteins (Deyoung, 2007).
Interestingly, the p63 transcription factor was recently
implicated in mitotic spindle orientation during asymmetricTable 1 A summary of the investigations of mutations in APC, Lgl
potential link to asymmetric stem cell division (ACD)
Roles for tumor suppressors in asymmetric stem cell division and
Fly Mouse
Apc ACD linked to tumor formation ACD; Tum
Lgl ACD linked to tumor formation ACD linked
Brat ACD linked to tumor formation Tumor for
p63 ND ACD linked
ACD linked to tumor formation, the protein has defined role in asymmet
formation. ACD; tumor formation, the protein has defined role in asym
functions have not been experimentally linked. Tumor formation, the pr
yet been described.
⁎ The full-length p63 isoform is referred to here. ND , not determine
Drosophila. This table encompasses the investigations cited in this revepidermal stem cell division, one of the first studies to
examine in vivo asymmetric stem cell division in a
mammalian system (Lechler and Fuchs, 2005). Accordingly,
its role in establishing spindle orientation may be related to
the proliferative potential of dividing cells, a critical
mediator in cancer progression. Stratified epithelial cells
undergo symmetric and asymmetric divisions during normal
development. Under these conditions, the mitotic spindle
orients perpendicular to the basement membrane and
mammalian homologues of the apical complex localize to
the apical cortex prior to cell division. In contrast, in a p63
null mouse mutant, the spindle is parallel in orientation and
the complex is mislocalized (Lechler and Fuchs, 2005),
resulting in the disruption of tissue organization.
In general, misregulation of any of the p63 isoforms is
implicated in human tumor formation; however, a definitive
and consistent correlation between expression of the p63
isoforms and either cancer initiation or progression remains
controversial (Westfall, 2004; Deyoung, 2007). Many human
cancers harbor an overexpression of one or more isoforms of
p63, supporting an oncogenic role in tumorigenesis. In
addition, some studies indicate that overexpression of p63
can cause an epithelial-to-mesenchymal transition, leading to
an upregulation of genes involved in cell migration and
invasion during metastasis (Koster et al., 2006). Interestingly
and conversely, human bladder and urothelial cancers exhibit
loss of p63, supporting a tumor suppressive role (Koga et al.,
2003; Park et al., 2000). In either situation and in light of the
mouse and fly data, it is possible that either over- or
underexpression of p63 may contribute to aberrant spindle
orientation in the stem cell population. Clearly, the existence
of multiple p63 isoforms complicates our appreciation of its
role in asymmetric stem cell division, although the extensive
descriptions of the function of p63 in epithelial stem cell
biology combined with the recent spindle orientation studies
in the mouse (Lechler and Fuchs, 2005) provide an undeniable
basis for further examination of the role of p63 in spindle
orientation in asymmetric stem cell division.Conclusion
In any self-renewing tissue, maintaining a balance between
stem cells and their differentiated progeny depends on, Brat, and p63 ⁎ from fly, mouse, and human cancers and their
cancer
Human
or formation Tumor formation
to tumor formation ACD linked to tumor formation
mation ACD; Tumor formation
to tumor formation Tumor formation
ric stem cell division that has been linked experimentally to tumor
metric stem cell division as well as tumor formation, but these
otein has defined role in tumor formation, but a link to ACD has not
d, as a full-length, p63 homologue has not been identified in
iew.
8 A.E. Powell et al.tightly regulated asymmetric stem cell division (Morrison and
Kimble, 2006). Recent investigations in invertebrate and
vertebrate systems have established that successful asym-
metric cell division is dependent on asymmetrically localized
proteins and mitotic spindle orientation. Proper execution of
these two cellular programs functions in cell fate determi-
nation to control whether a cell assumes either a stem or a
differentiated identity. When mutations occur in genes
involved either directly or downstream of the intrinsic or
extrinsic cues governing these mechanisms, the resulting
asymmetric cell division is abnormal and leads to uncon-
trolled amplification of stem cell populations.
The tumor suppressor proteins described in this review
represent just four examples of molecules that regulate
developmental or adult homeostatic asymmetric cell divi-
sion, but we highlight the critical need for further investiga-
tions regarding the relevance of these tumor suppressors in
disrupting asymmetric stem cell division in human cancer.
Indeed, a precedent for such translational research is ongoing
in work addressing Drosophila cell polarity determinants and
proliferation control, and their implications on mammalian
cancer progression (Bilder, 2004; Grifoni et al., 2004; Grifoni
et al., 2007; Caussinus and Gonzalez, 2005; Gonzalez, 2007;
Hawkins and Russell, 2008). Studies emerging from this
nascent field may implicate a critical and novel role for these
proteins in early tumor initiation and asymmetric stem cell
division of a putative cancer stem cell population.
Direct links between tumorigenesis and asymmetric stem
cell division do exist in mutants of the well-documented
mammalian tumor suppressor, APC, the p53 family member,
p63, and the Drosophila polarity protein, Lgl (summarized in
Table 1). Mutations in these tumor suppressors are associat-
ed with advanced tumor progression, metastasis, and poor
patient prognosis, yet their function in aberrant asymmetric
stem cell division in cancer has not been fully explored
despite the amount of overwhelming evidence derived from
lessons in developmental biology. The findings we present
here likely represent but a few examples of how clues from
developmental biology can illuminate key insights into
cancer cell biology, specifically, the study of aberrant
asymmetric stem cell division of human tissue stem cells
and the expansion of a cancer stem cell pool in tumorigen-
esis. Clearly defining a role for the underlying mechanism
driving aberrant expansion of a cancer stem cell pool
provides further justification for targeting the cancer stem
cell as an important therapeutic approach for treatment of
disease.
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